Home Top Movers What Caused Amneal Pharmaceuticals (AMRX) To Rise 4% After-Hours On Friday? –...

What Caused Amneal Pharmaceuticals (AMRX) To Rise 4% After-Hours On Friday? – Here Is An Explanation

Shares of fully integrated pharmaceutical company Amneal Pharmaceuticals Inc (AMRX) raised +3.9% on Friday after ring of the bell. The new came on the heels of news about the company receiving an Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What actually happened?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


The Bridgewater, NJ.-based AMRX manufactures, distributes, and develops generic and specialty pharmaceutical products. It works together to deliver high-quality medicines to patients primarily within the United States and also through activities in Asia, the European Union, and North America. Amneal has an extensive portfolio of 250 or more product families, and it continues expanding its product universe to cover a broad range of therapeutic areas, including biosimilars, in a variety of dosage forms. Also within the Company’s Specialty segment focused primarily on central nervous system and endocrine disorders, the Specialty segment markets a portfolio of branded pharmaceuticals as well.

Read More

Amneal on Friday announced that it had received FDA approval for a hybrid transdermal treatment containing 150mcg/day Norelgestromin and 35mcg/day Ethinyl Estradiol.

  • Amneal has been awarded 180 days of exclusivity by the FDA concurrent with its approval as a Competitive Generic Therapy (CGT).
  • There is a generic version of the reference listed drug (RLD) Ortho Evra in Amneal’s Norelgestromin and Ethinyl Estradiol Transdermal System.
  • The product will be marketed as a 12.5 cm2 patch with a proprietary name called Zafemy.
  • The product will be recommended to Women whose BMI is 30 kg/m2 or below and who are advised to use a combined hormonal contraceptive to avoid pregnancy.
  • Females weighing more than 198 pounds (90 kg) may have less success preventing pregnancy with Zafemy.
  • The company expects to start commercializing the product on March 1, 2021.

    Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Finally,

A leading healthcare data and analytics provider, IQVIA, calculates that the U.S. sales for all Xulane products were $332 million in the twelve months ended December 2020. Mylan’s Xulane is currently the only option available on the market, but Zafemy is the most complete alternative for the same which indicates growth opportunity for the newly launched product at an impressively high rate.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Himax Technologies, Inc. (HIMX) Stock Climbing After Promising Q1 2021 Financial Reports

Himax Technologies, Inc. (HIMX) stock prices were down by 6.97% as of the market closing on May 5th 2021, bringing the price per share...

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went...

Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit

Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to...

Shares of Cinedigm Corp. (CIDM) are climbing high in the premarket. What’s Going On?

Cinedigm (NASDAQ:CIDM), a distributor of various movies, television and other digital content, managing a library of distribution rights to several thousand titles and different...

Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?

Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.